Article Information
History
- January 5, 2024.
Article Versions
- Version 1 (January 13, 2022 - 15:54).
- Version 2 (April 13, 2023 - 08:54).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Alexandra C Gillett1,2,*,†,
- Saskia P Hagenaars1,2,†,
- Dale Handley1,
- Francesco Casanova3,
- Katherine G Young3,
- Harry Green3,
- Cathryn M Lewis1,2,4,† and
- Jess Tyrrell3,†
- 1Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK
- 2NIHR Maudsley Biomedical Research Centre, South London and Maudsley NHS Trust, London, UK
- 3Clinical and Biomedical Science, Institute of Health and Life Sciences, University of Exeter, Exeter, UK
- 4Department of Medical and Molecular Genetics, Faculty of Life Sciences and Medicine, King’s College London.
- ↵*Corresponding author: Alexandra C Gillett, Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK alexandra.a.gillett{at}kcl.ac.uk
↵† contributed equally
Posted January 05, 2024.
The impact of major depressive disorder on glycaemic control in type 2 diabetes: a longitudinal cohort study using UK Biobank primary care records
